rtki cpd has been researched along with g(m3) ganglioside in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böhmer, FD; Fernández, LE; Greiser, U; Lage, A; Perez, R; Sánchez, B; Suarez Pestana, E | 1 |
Choo, YK; Jin, JW; Jung, JU; Jung, KY; Kim, SM; Ko, K; Ryu, JS; Yang, HJ; You, HK | 1 |
2 other study(ies) available for rtki cpd and g(m3) ganglioside
Article | Year |
---|---|
Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).
Topics: Adenocarcinoma; Benzylidene Compounds; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Membrane; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; G(M3) Ganglioside; Humans; Lung Neoplasms; Nitriles; Phosphorylation; Protein Tyrosine Phosphatases; Quinazolines; Radioligand Assay; Signal Transduction; Tumor Cells, Cultured; Tyrphostins | 1997 |
Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors.
Topics: Alkaline Phosphatase; Cell Differentiation; Epidermal Growth Factor; ErbB Receptors; G(M3) Ganglioside; Gangliosides; Humans; Mesenchymal Stem Cells; Osteoblasts; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Tyrphostins | 2008 |